Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated aurora kinase B inhibition

Radiation Research

Volumn 175, Issue 4, 2011, Pages 444-451

  Niermann, Kenneth J ^a   Moretti, Luigi ^a   Giacalone, Nicholas J ^a   Sun, Yunguang ^a   Schleicher, Stephen M ^a   Kopsombut, Prapaporn ^a   Mitchell, Lauren R ^a   Kim, Kwang Woon ^a   Lu, Bo ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AURORA B KINASE; BARASERTIB; CESIUM 137; HISTONE H2AX;

ARTICLE; CARCINOMA CELL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL LINE; CLONOGENIC ASSAY; DNA DAMAGE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IRRADIATION; POLYPLOIDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RADIATION INJURY; RADIOSENSITIVITY;

ANDROGENS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PHOSPHORIC ACID ESTERS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; QUINAZOLINES; RADIATION TOLERANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 79953297717     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR2317.1     Document Type: Article

References (25)

1. Cancer Facts and Figures 2008. American Cancer Society, Atlanta, 2008.
2. R. R. Adams, H. Maiato, W. C. Earnshaw and M. Carmena, Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation. J. Cell Biol. 153, 865-880 (2001).
3. S. Hauf, R. W. Cole, S. LaTerra, C. Zimmer, G. Schnapp, R. Walter, A. Heckel, J. van Meel, C. L. Rieder and J. M. Peters, The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 161, 281-294 (2003). (Pubitemid 36529847)
4. P. D. Andrews, E. Knatko, W. J. Moore and J. R. Swedlow, Mitotic mechanics: the auroras come into view. Curr. Opin. Cell Biol. 15, 672-683 (2003). (Pubitemid 37487960)
5. D. C. Altieri, Molecular circuits of apoptosis regulation and cell division control: the surviving paradigm. J. Cell Biochem. 92, 656-663 (2004). (Pubitemid 44264257)
6. M. Carmena and W. C. Earnshaw, The cellular geography of aurora kinases. Nat. Rev. Mol. Cell. Biol. 4, 842-854 (2003). (Pubitemid 37411723)
7. E. C. Lee, A. Frolov, R. Li, G. Ayala and N. M. Greenberg, Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res. 66, 4996-5002 (2006). (Pubitemid 43844918)
8. P. Chieffi, L. Cozzolino, A. Kisslinger, S. Libertini, S. Staibano, G. Mansueto, G. De Rosa, A. Villacci, M. Vitale and D. Tramontano, Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66, 326-333 (2006). (Pubitemid 43191232)
9. T. Ota, S. Suto, H. Katayama, Z. B. Han, F. Suzuki, M. Maeda, M. Tanino, Y. Terada and M. Tatsuka, Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. 62, 5168-5177 (2002). (Pubitemid 35024587)
10. K. Araki, K. Nozaki, T. Ueba, M. Tatsuka and N. Hashimoto, High expression of Aurora-B/Aurora and Ipll-like midbodyassociated protein (AIM-1) in astrocytomas. J. Neurooncol. 67, 53-64 (2004). (Pubitemid 38418249)
11. A. A. Kulkarni, M. Loddo, E. Leo, M. Rashid, K. L. Eward, T. R. Fanshawe, J. Butcher, A. Frost, J. A. Ledermann and K. Stoeber, DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. Clin. Cancer Res. 13, 6153-6161 (2007). (Pubitemid 350075075)
12. W. F. Zeng, K. Navaratne, R. A. Prayson and R. J. Weil, Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme. J. Clin. Pathol. 60, 218-221 (2007).
13. R. W. Wilkinson, R. Odedra, S. P. Heaton, S. R. Wedge, N. J. Keen, C. Crafter, J. R. Foster, M. C. Brady, A. Bigley and S. Green, AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin. Cancer Res. 13, 3682-3688 (2007). (Pubitemid 46955132)
14. Y. Tao, P. Zhang, F. Girdler, V. Frascogna, M. Castedo, J. Bourhis, G. Kroemer and E. Deutsch, Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152. Oncogene 27, 3244-3255 (2008). (Pubitemid 351733390)
15. K. W. Kim, R. W. Mutter, C. D. Willey, T. K. Subhawong, E. T. Shinohara, J. M. Albert, G. Ling, C. Cao, Y. J. Gi and B. Lu, Inhibition of surviving and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests. Int. J. Radiat. Oncol. Biol. Phys. 67, 1519-1525 (2007). (Pubitemid 46467182)
16. E. Walsby, V. Walsh, C. Pepper, A. Burnett and K. Mills, Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts. Haematologica 93, 662-669 (2008). (Pubitemid 351669305)
17. J. Li, M. G. Anderson, L. A. Tucker, Y. Shen, K. B. Glaser and O. J. Shah, Inhibition of Aurora B kinase sensitizes a subset of human glioma cells to TRAIL concomitant with induction of TRAIL-R2. Cell Death Differ. 16, 498-511 (2009).
18. J. Yang, T. Ikezoe, C. Nishioka, T. Tasaka, A. Taniguchi, Y. Kuwayama, N. Komatsu, K. Bandobashi, K. Togitani and A. Yokoyama, AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 110, 2034-2040 (2007). (Pubitemid 47443920)
19. A. van Bokhoven, M. Varella-Garcia, C. Korch, W. U. Johannes, E. E. Smith, H. L. Miller, S. K. Nordeen, G. J. Miller and M. S. Lucia, Molecular characterization of human prostate carcinoma cell lines. Prostate 57, 205-225 (2003). (Pubitemid 37267805)
20. K. V. Gurova, O. W. Rokhlin, A. V. Budanov, L. G. Burdelya, P. M. Chumakov, M. B. Cohen and A. V. Gudkov, Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells. Cancer Res. 63, 2905-2912 (2003). (Pubitemid 36667163)
21. J. Galleani, C. Miranda, M. A. Pierotti and A. Greco, H2AX phosphorylation and kinetics of radiation-induced DNA double strand break repair in human primary thyrocytes. Thyroid 19, 257-264 (2009).
22. J. P. Banath, S. H. MacPhail and P. L. Olive, Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 64, 7144-7149 (2004). (Pubitemid 39331029)
23. H. Mahrhofer, S. Burger, U. Oppitz, M. Flentje and C. S. Djuzenova, Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation. Int. J. Radiat. Oncol. Biol. Phys. 64, 573-580 (2006). (Pubitemid 43083447)
24. L. C. Riches, A. M. Lynch and N. J. Gooderham, Early events in the mammalian response to DNA double-strand breaks. Mutagenesis 23, 331-339 (2008).
25. M. K. Addepalli, K. B. Ray, B. Kumar, R. L. Ramnath, S. Chile and H. Rao, RNAi-mediated knockdown of AURKB and EGFR shows enhanced therapeutic efficacy in prostate tumor regression. Gene Ther. 17, 352-359 (2010).